The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbAlc).

 
Web www.patentalert.com

< Modified antibodies to prostate-specific membrane antigen and uses thereof

< Bifunctional chelating agent for actinium

> Expressed ligand-vascular intercellular signaling molecule

> Method for identifying compounds in vitro that modulate the dysregulation of transcription of transcription mediated by mutant huntingtin protein
~ 00256